Industry Satellite Symposia
Switch To Module
ESMO Congress 2021 - Conference Calendar
On-demand Educational sessions
On-demand Special Symposia
On-demand Multidisciplinary sessions
On-demand ePosters
Industry Satellite Symposia
Digital Evaluations
Everything
Everything
Session Title
Session Number
Presentation Title
Presentation Number
Author
Presenter
Chair
Filter By
Day
Select All
Deselect All
Fri, 17.09.2021
12
Sat, 18.09.2021
11
Sun, 19.09.2021
12
Mon, 20.09.2021
11
Tue, 21.09.2021
11
Room
Select All
Deselect All
Channel 3
14
Channel 4
15
Channel 5
13
Channel 6
15
Session Type
Select All
Deselect All
Industry Satellite Symposium
57
Presentation Type
Select All
Deselect All
Invited Speaker
57
Presentation Topic
Select All
Deselect All
General interest
57
Cancel
Clear
Search
Advanced Search
Sign in
Scheduled sessions
On-demand Educational sessions
On-demand Special Symposia
On-demand Multidisciplinary sessions
On-demand ePosters
Industry Satellite Symposia
Final Programme PDF
Browsing Over 57 Sessions
Sort By
Session Number
Upcoming First
Relevance
Session Number
Session Datetime
Servier - Extend the continuum of care and improve patient outcomes in mGC and mCRC
(ID 154)
Time
17:35 - 19:05
Janssen - Expanding horizons for the targeted management of EGFR-Positive NSCLC
(ID 119)
Time
18:45 - 20:15
Pfizer Oncology - Expert Perspectives in ALK+NSCLC: a round table discussion
(ID 110)
Time
08:45 - 09:45
Sanofi Genzyme - Optimizing Immuno-oncology in NSCLC: What Do We Know and Where Should We Go?
(ID 144)
Time
18:45 - 20:15
AstraZeneca - From Breast Cancer Biology to Therapy
(ID 101)
Time
08:45 - 10:15
Bristol Myers Squibb - From Rational to Daily Practice: Navigating Through 1L IO-based Treatment Options in Advanced RCC
(ID 135)
Time
08:45 - 09:45
AstraZeneca - Redefining long-term outcomes in newly diagnosed advanced ovarian cancer: Expert perspectives on integrating personalized medicine
(ID 125)
Time
08:45 - 10:15
Amgen - Precision therapy in NSCLC: the dawn of KRAS G12C inhibition
(ID 115)
Time
10:30 - 12:00
PER Global, LLC - Leveraging Antibody-Drug Conjugates in Cancer Care: Evolving Approaches to Bridge Clinical Gaps in Breast, GI, and Lung Tumors
(ID 150)
Time
10:30 - 12:00
MSD - Evolving Treatment Landscape in HNSCC
(ID 106)
Time
18:45 - 20:15
AstraZeneca - Emerging immuno-oncology options in metastatic NSCLC and SCLC: Clinical evidence and future perspectives
(ID 140)
Time
10:30 - 12:00
GSK - Biomarkers for cancer immunotherapy: the importance of dMMR/MSI-H for predicting response in solid tumors
(ID 130)
Time
18:45 - 20:15